7th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine

Mar 17-18, 2023

|

Chicago, United States of America





Cell Science, Stem Cell Research and Regenerative Medicine



 

Welcome message  

LexisConferences invites you to show your presence and share your ideas and information related to Stem Cells at the 7th Annual Congress on Cell Sciences and Regenerative Medicine that is going to be held on March 17-18, 2023, Chicago, USA. Stem Cell 2023 will provide a platform for experts, researchers, students, and scientists, to give a deep concept about the topic through their oral talks, and presentations. The main aim of this conference is to explore knowledge and discuss queries related to Stem Cells.

About Conference

LexisConferences is organizing the 7th Annual Congress on Cell Sciences, Stem Cells, and Regenerative Medicine Conference will provide a common platform to leaders in research, industrial experts, and trainees so that we can share the new ideas and facts  in the respective fields leading to the development of new generation stem cell technologies. The objective of the conference is to make people aware of stem cells and their related diseases and treatment. Stem cell embryology can be used to regenerate or repair diseased tissue or organs.

In stem cell transplants, stem cells either replace diseased or chemo-damaged cells or work with the immune system of the donor to combat certain cancers and blood-related illnesses such leukaemia, lymphoma, neuroblastoma, and multiple myeloma.
In addition, if the spine doesn't heal properly, some spinal cord injuries might cause progressive nerve damage. According to one experiment, nearly 45% of patients who received stem cell therapy saw excellent outcomes. For innovative medical therapies, stem cells hold out considerable promise.
Some kinds of stem cells can be used by researchers to test new medications for quality and safety prior to testing them on humans. This kind of testing will probably first directly affect the development of drugs for cardiac toxicity testing.

Speakers, delegates, scholars, researchers, and keynote speakers will mark their presence at the conference. We respect your valuable time and appreciate your till date contribution to the area of Cell Science.

Brochure

 

 

Why attend?

Stem Cell 2023 Conference will provide an ideal platform to express the views and knowledge in deep about the latest research work done in the stem cell field. Debate to reduce the gaps and priorities which will lead to the development of next-generation stem cell technologies to measure the future aspects and updates related to the stem cells. The event will provide an opportunity to interact with well-known speakers and industry experts.

Target audience

Keynote Speakers | Renowned Speakers | Eminent Personalities | Association Heads | Directors | CEO | Organization Or Institution Heads | Stem Cell Laboratory Heads & Researchers | Post-Docs | Students Along With Companies Can Be Targeted As The Audience

Abstract Submission Details
The organizing committee of the Stem Cell 2023 Conference would like to invite speakers to submit their research for inclusion in the Stem Cells 2023 scientific program. 

Submit your abstract online at Speaker abstract (or)  Email to: [email protected]

Market analysis-

The stem cell market has been increased continuously due to an increase in awareness about the research and stem cell therapies both in the government and private sector. The global market of stem cells has a CAGR of 36.52% from 2017-2021 and is dominated by the USA primarily (13.9% CAGR) followed by Europe (13.4% CAGR). Asia-Pacific shows the highest growth in the stem cells market. About 77.45 of the total US market about 77.45 of the total US market. The development of developing markets, the substitution of induced pluripotent stem cells for embryonic stem cells, and the emergence of novel stem cell treatments provide promising growth prospects for the industry's top players.

The primary drivers driving this market are increased financing from the public and private sectors as well as growing global awareness of stem cell therapies and research. The global market for stem cells has been significantly boosted by an increase in medicinal research projects that are being supported by governments around the world. But it is anticipated that the high cost of stem cell therapy and strict government laws against stem cell harvesting would limit the growth of the global stem cells industry.

The application of regenerative medicine generates significant money at the moment.

In contrast to Europe By the conclusion of the forecast period of 2018–2026, the stem cell market is anticipated to develop at a CAGR of 9.45%. R&D investment is the main factor driving the market forward.

The use of stem cells in regenerative therapies has led to an increase in their use in the fields of haematological and neurological conditions, as well as infertility, Crohn's disease, systemic lupus, and organ transplantation.

The market for stem cells and regenerative medicines operates on a number of factors, including product type, application, sources, region, and users. Human embryonic stem cells, adult stem cells, IPsec, and other product categories make up the stem cells industry. Regenerative medications, on the other hand, used these stem cells' capacity to regenerate, repair, and replace tissues or organs

2019/10/03/(The Expresswire) The Stem Cell Therapy Market study includes cost-benefit analysis, the most recent market trends, and dynamics analysis of the leading players with an emphasis on the size, prices, expansion rate, competition, and value chain analysis of those market leaders. The market environment and its growth expectations over the ensuing years are covered in the research. The Stem Cell Therapy Market 2019 research offers practical and useful market data that will help you promote concepts.

It provides in-depth information and enhances variability of the global market for stem cell therapy to assist you in choosing the best course of action. It includes comprehensive data on the most recent advancements, manufacturing trends, industry structural changes, and shifting market dynamics. The market for stem cell therapy will expand at a CAGR of 36.52% from 2017 to 2021 analysis of the leading players with an emphasis on the size, prices, expansion rate, competition, and value chain analysis of those market leaders. The market environment and its growth expectations over the ensuing years are covered in the research. The Stem Cell Therapy Market 2019 research offers practical and useful market data that will help you promote concepts.

Stem Cell Market

The growing number of clinical trials being conducted globally is helping the stem cell market expand. The majority of stem cell therapy trials are being conducted in North America, primarily the United States. With approximately 77.4% of the whole North American market, the United States dominates the industry in both the product and banking services areas.

But Asia-Pacific is expanding at the fastest rate. In regenerative medicine, stem cells play a significant role, particularly in dermatology. Oncology, however, is anticipated to experience the fastest growth rate due to the abundance of pipeline drugs available for the treatment of tumours or cancers. The number of regenerative medicine facilities is predicted to grow along with the stem cell market.

The most popular stem cell therapy is bone marrow transplant, which is followed by treatments using umbilical cord blood.

Research is being done to create different sources such as using stem cells from different sources (such as skin, bone marrow, and cord blood) to treat diseases like diabetes, heart disease, and neurodegenerative disorders.

Market researchers anticipate that from 2017 to 2021, the global market for stem cell therapy will expand at a CAGR of 36.52%.

With the backing of government initiatives, stem cell banking is becoming more significant. In emerging nations, there are more stem cell banks than ever before, which is helping the market expand. Additionally, the market has benefited from individuals being more aware of stem cell storage. The United States contributed the highest share to the region's overall stem cell market, which was dominated by North America. The Sanford Clinical Center for Stem Cells at the University of A clinical experiment to evaluate the safety of neural stem cell-based therapy in patients with persistent spinal cord damage has been announced by the California, San Diego (UCSD) Health System. The implanted stem cells were expected to differentiate into new neurons that would take the place of severed or damaged nerve connections and perhaps restore at least some motor and sensory functions. The growth of the stem cell market has been aided by the vast number of stem cell studies conducted across the US to evaluate the safety of neural stem cell-based therapy in patients with persistent spinal cord damage has been announced by the California, San Diego (UCSD) Health System. The implanted stem cells were expected to differentiate into new neurons that would take the place of severed or damaged nerve connections and perhaps restore at least some motor and sensory functions. The growth of the stem cell market has been aided by the vast number of stem cell studies conducted across the US.

There are many significant participants in the fiercely competitive stem cell business. Few of the big competitors now control the majority of the market in terms of market share. Major market players like Thermo Fisher Scientific, Qiagen NV, Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies are present, which is resulting in an increase in the level of market competition. The key players' improvements to stem cell technology and product developments are escalating their competitive competition.

America's and the world's societies are significantly impacted by cancer. In 2018, the National Cancer Institute predicted that 1,735,350 new instances of cancer will be diagnosed in the country, and 609,640 people would pass away from the disease. The population is growing, which is causing this rising medical burden. Some diseases, including leukaemia, multiple myeloma, neuroblastoma, and some forms of lymphomas, can be treated by a bone marrow or stem cell transplant. Due to their greater totipotency and longer longevity than adult stem cells, which have a shorter lifespan and lower totipotency, embryonic stem cells (ESC) are the primary source of stem cells for therapeutic uses. However, the application of ESCs to research and medical

The market is expanding positively, but because stem cell-based research is receiving more attention and could increase clinical applications, stem cell therapy may be prohibitively expensive, still impede its development.

It provides in-depth information and enhances market variations for the global stem cell therapy market to assist you in settling on the winning plan. It includes comprehensive data on the most recent advancements, manufacturing trends, industry structural changes, and shifting market dynamics. The market for stem cell therapy will expand at a CAGR of 36.52% from 2017 to 2021. While the European stem cell market is anticipated to expand at a CAGR of 9.45% between 2018 and 2026. The market is developing primarily as a result of rising R&D expenditures in adult stem cell research in the area, ease of administration, and the rising prevalence of chronic diseases as a result of demographic shifts in lifestyle. The UK, France, Germany, Spain, Italy, and the rest of Europe are the nations that made up the analysis of the European stem cell market. The majority of these nations have stable economies, allowing their citizens to spend more on healthcare. Based on technology, product, and applications, the Europe stem cell market has been divided into segments in this study.

Stem Cells 2021 Report

LexisConferences Conferences hosted the event “6th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine to be held from September 06-07, 2021” .The conferences were organized with a focus on the themes “Stem Cells A Boon for COVID-19 Treatment” was a great success where eminent keynote speakers from various reputed companies and Universities made their resplendent presence and addressed the gathering.

The event proceedings were carried out through several Scientific-sessions and plenary lectures, LexisConferences would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of 6th Annual congress on Cell sciences, Stem Cells and Regenerative Medicine. We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Stem Cells 2021.

Stem Cells 2021 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers Alejandro De La Parra-Solomon from World Academy of Medical Sciences, Mexico; Ahmed G Hegazi from Academy of Scientific Research & Technology, Egypt; Alireza Heidari from Cancer Research Institute, USA; Jenny Wang from Harvard Medical School, Australia; CP Abdolrasoul Aleezaadeh from Brooklyn Central University, New York; Kazi Ahsan Jamil from National University of Singapore, Japan have given a wonderful talk which makes allows the delegates and other attendees to gain the knowledge about main course of the event.

Stem Cells 2021 Organizing Committee would like to thank the Moderator of the conference, Alireza Heidari from Cancer Research Institute, USA, who contributed a lot for the smooth functioning of this event and for taking up the responsibility to coordinate during the sessions for smooth functioning of this event. We are indebted to your support.

LexisConferences conferences also took the privilege of felicitating Stem Cells 2021 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.

We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events. We would also like to thank Chairs and Co-chairs of the conference, Alireza Heidari from Cancer Research Institute, USA; Jenny Wang from Harvard Medical School, Australia; CP Abdolrasoul Aleezaadeh from Brooklyn Central University, New York; Kazi Ahsan Jamil from National University of Singapore, Japan for a being a great support for our event to be a grand success. A series of lectures by distinguished professionals discussed the recent trends and issues in inter-disciplinary Rheumatology and its technical advancements.

With a great response and feedback which we received from participants and supporters from Stem Cells 2021, we are proud to announce our upcoming conferences in the Series 7th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine on March 17-18, 2023 in Chicago, United States Of America with the theme of Promising a New Path for Stem Cells and Regenerative Medicines.

The main aim of this conference is to solicit the gracious presence of our honourable, to the upcoming conference “7th Annual Congress on Cell Science, Stem Cell Research and Regenerative Medicine ” that is going to be held during March 17-18, 2023 in Chicago, United States Of America to share and exchange their knowledge. It is an International platform for business delegates, B2B meetings, poster presentations, workshops, symposia, networking and more. It will offer a platform wherein you can ensure enormous exposure and networking by exhibiting products and services. Grab the opportunities, and share your innovative ideas, new technologies and recent researches.

Stem Cells 2023 witnesses an amalgamation of peerless speakers who enlightened the gathering with their contribution towards the prevention of Stem Cell related difficulties, its effects and treatment on Oncology.

For being a Experts in Stem Cells and Regenerative Medicine, we hope that this platform gives knowledge and new updates by undergoing with the several interactive sessions to encourage the exchange of innovative ideas in the field of Stem Cells and its advancements, in that all the session talks are consider to be a great talks which makes the delegates, exhibitor, collaborators and other speakers feels so much interesting.

Being a significant expert in this area we would like to Invite you as an International Organizing Committee Members, Speakers, Keynote speakers, Young Research forum, Sponsors and Exhibitor, etc for Stem Cells 2023 .Our goal is to deliver an outstanding program which covers the entire spectrum of research & innovations in Oncology, Stem Cell and share the cross-cultural experiences of various principles and practices.

The centre of the activity of Stem Cells 2023 is to produce the clear visual definition by undergoing with Oral Presentation, Poster presentation, Workshop, Exhibition, networking and interacting session. With the feedback from your renowned Speakers, we have added some of the new Session Tracks that need to be focused such as such as Stem Cells| Regenerative Medicine| Computational Biology| Immunology| Tumor Cell Science| Novel Stem Cells| Drugs and Clinical Development| Stem Cell Embryology.

With the great support we have successfully completed Stem Cells 2021 and we are expecting huge response and support from the Stem Cell and Regenerative Medicine, Doctors, Oncology Professionals, Young researchers, Students, Delegates, Directors and other Stem Cell and Regenerative Medicine related companies to have your gracious presence at Stem Cells 2023 on March 17-18, 2023 in Chicago, USA to make this congress a great successful event of the year 2023

Join our team Stem Cells 2023 at this beautiful city of USA and let’s make this professional gathering a Great success

Contact us:

Eva Wilson| Program Manager

Stem Cells 2023

Website: https://www.lexismeeting.com/stemcellscongress

 

Stem cells banking values from 2012-2023

Stem cells help develop oncology disorder segments and in research areas leading to the development of new therapies like regenerative therapies use of induced pluripotent stem cells. These stem cells are used as an alternative to embryonic stem cells so that they can contribute high revenue.

The main advantage in market development is the high totipotency and indefinite lifespan of stem cells. The top companies competing in the market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma competing in the market for stem cell products are Thermo Fischer Scientific, Qiagen NV, Sigma Aldrich, Becton, Dickinson and company, and stem cell technologies.

Societies Of USA

American Society for Cell Biology (ASCB).

ASGCT - American Society of Gene & Cell Therapy.

American Society for Biochemistry and Molecular Biology.

 

Societies Of UK

British Society for Gene and Cell Therapy.

UK Society for Cell Culture Biotechnology.

International Society for Stem Cell Research.

Stem cells and human health | Royal Society.

 

Societies Of France

French Society for Stem Cell Research

Stem Cells and Technoscience: Sociology of the Emergence

Frontiers in Cancer Research and Therapy

 

Societies Of Japan

The Japanese Society for Regenerative Medicine

Japan's Stance on Stem Cell Research

The Japan Society of Transfusion Medicine and Cell Therapy

 

Lucy
Dr CP Abdolrasoul Aleezaadeh
Brooklyn Central UniversityGreen Lake University

Lucy
Dr Jenny Wang
Harvard Medical SchoolChildrens Cancer Institute

Lucy
Dr Alireza Heidari
Cancer Research InstituteAmerican International Standards Institute

Lucy
Dr Ahmed G Hegazi
Academy of Scientific Research Technology

Lucy
Alejandro De La Parra-Solomon

Lucy
Mrs Kelli Mauric
Owner Entreprenuer at Balance the Brain Professional Corp

Lucy
Dr Pradeep Mahajan
StemRx Bioscience Solutions Pvt Ltd

Lucy
Kazi Ahsan Jamil
National University of Singapore

Program Overview